Literature DB >> 26364901

Report of a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris phenotype, and schwannomatosis.

Nathan Gossai1, Jaclyn A Biegel2, Ludwine Messiaen3, Susan A Berry4, Christopher L Moertel1.   

Abstract

We report a patient with a constitutional missense mutation in SMARCB1, Coffin-Siris Syndrome (CSS), and schwannomatosis. CSS is a rare congenital syndrome with characteristic clinical findings. This thirty-three-year-old man was diagnosed early in life with the constellation of moderate intellectual disability, hypotonia, mild microcephaly, coarse facies, wide mouth with full lips, hypoplasia of the digits, and general hirsutism. At age 26, he was found to have schwannomatosis after presenting with acute spinal cord compression. Blood and tissue analysis of multiple subsequent schwannoma resections revealed a germline missense mutation of SMARCB1, acquired loss of 22q including SMARCB1 and NF2 and mutation of the remaining NF2 wild-type allele-thus completing the four-hit, three-event mechanism associated with schwannomatosis. Variations in five genes have been associated with the Coffin-Siris phenotype: ARID1A, ARID1B, SMARCA4, SMARCB1, and SMARCE1. Of these genes, SMARCB1 has a well-established association with schwannomatosis and malignancy. This is the first report of a patient with a constitutional missense mutation of SMARCB1 resulting in CSS and subsequent development of schwannomatosis. This finding demonstrates that a SMARCB1 mutation may be the initial "hit" (constitutional) for a genetic disorder with subsequent risk of developing schwannomas and other malignancies, and raises the possibility that other patients with switch/sucrose non-fermenting (SWI/SNF) mutations may be at increased risk for tumors.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Coffin-Siris syndrome; schwannomatosis

Mesh:

Substances:

Year:  2015        PMID: 26364901     DOI: 10.1002/ajmg.a.37356

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  13 in total

Review 1.  Germline variants in SMARCB1 and other members of the BAF chromatin-remodeling complex across human disease entities: a meta-analysis.

Authors:  Till Holsten; Susanne Bens; Florian Oyen; Karolina Nemes; Martin Hasselblatt; Uwe Kordes; Reiner Siebert; Michael C Frühwald; Reinhard Schneppenheim; Ulrich Schüller
Journal:  Eur J Hum Genet       Date:  2018-04-30       Impact factor: 4.246

2.  Genomic DNA Methylation Signatures Enable Concurrent Diagnosis and Clinical Genetic Variant Classification in Neurodevelopmental Syndromes.

Authors:  Erfan Aref-Eshghi; David I Rodenhiser; Laila C Schenkel; Hanxin Lin; Cindy Skinner; Peter Ainsworth; Guillaume Paré; Rebecca L Hood; Dennis E Bulman; Kristin D Kernohan; Kym M Boycott; Philippe M Campeau; Charles Schwartz; Bekim Sadikovic
Journal:  Am J Hum Genet       Date:  2018-01-04       Impact factor: 11.025

3.  Double somatic SMARCB1 and NF2 mutations in sporadic spinal schwannoma.

Authors:  Irene Paganini; Gabriele Lorenzo Capone; Jeremie Vitte; Roberta Sestini; Anna Laura Putignano; Marco Giovannini; Laura Papi
Journal:  J Neurooncol       Date:  2017-12-11       Impact factor: 4.130

4.  Coffin-Siris syndrome in two chinese patients with novel pathogenic variants of ARID1A and SMARCA4.

Authors:  Mingjie Liu; Linlin Wan; Chunrong Wang; Hongyu Yuan; Yun Peng; Na Wan; Zhichao Tang; Xinrong Yuan; Daji Chen; Zhe Long; Yuting Shi; Rong Qiu; Beisha Tang; Hong Jiang; Zhao Chen
Journal:  Genes Genomics       Date:  2022-03-30       Impact factor: 2.164

Review 5.  The molecular pathogenesis of schwannomatosis, a paradigm for the co-involvement of multiple tumour suppressor genes in tumorigenesis.

Authors:  Hildegard Kehrer-Sawatzki; Said Farschtschi; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2016-12-05       Impact factor: 4.132

6.  SMARCA4 inactivating mutations cause concomitant Coffin-Siris syndrome, microphthalmia and small-cell carcinoma of the ovary hypercalcaemic type.

Authors:  Edoardo Errichiello; Noor Mustafa; Annalisa Vetro; Lucia Dora Notarangelo; Hugo de Jonge; Berardo Rinaldi; Debora Vergani; Sabrina Rita Giglio; Patrizia Morbini; Orsetta Zuffardi
Journal:  J Pathol       Date:  2017-07-25       Impact factor: 7.996

Review 7.  Chromatin Remodeling BAF (SWI/SNF) Complexes in Neural Development and Disorders.

Authors:  Godwin Sokpor; Yuanbin Xie; Joachim Rosenbusch; Tran Tuoc
Journal:  Front Mol Neurosci       Date:  2017-08-03       Impact factor: 5.639

8.  The hereditary nature of small cell carcinoma of the ovary, hypercalcemic type: two new familial cases.

Authors:  Leora Witkowski; Nancy Donini; Rebecca Byler-Dann; James A Knost; Steffen Albrecht; Andrew Berchuck; W Glenn McCluggage; Martin Hasselblatt; William D Foulkes
Journal:  Fam Cancer       Date:  2017-07       Impact factor: 2.375

Review 9.  Mutational Landscapes and Phenotypic Spectrum of SWI/SNF-Related Intellectual Disability Disorders.

Authors:  Nina Bögershausen; Bernd Wollnik
Journal:  Front Mol Neurosci       Date:  2018-08-03       Impact factor: 5.639

Review 10.  A heritable form of SMARCE1-related meningiomas with important implications for follow-up and family screening.

Authors:  E H Gerkes; J M Fock; W F A den Dunnen; M J van Belzen; C A van der Lans; E W Hoving; I E Fakkert; M J Smith; D G Evans; M J W Olderode-Berends
Journal:  Neurogenetics       Date:  2016-01-23       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.